GDPR represents an “urgent threat” to the EU’s research leadership roleMore than 5,000 collaborative studies were thwarted by GDPR rules in 2019 – but is there a way Share XGDPR represents an “urgent threat” to the EU’s research leadership rolehttps://pharmaphorum.com/views-and-analysis/gdpr-represents-an-urgent-threat-to-the-eus-research-leadership-role/
Cytisinicline – the solution to stop smoking?Whether present in electronic or combustible cigarettes, nicotine is a highly addictive substance. Dr Cindy Jacobs, chief medical Share XCytisinicline – the solution to stop smoking?https://pharmaphorum.com/views-and-analysis/the-need-for-nicotine-vaping-cessation-therapies/
The power of communication: engaging diverse groups in healthcareHumans are diverse and communications to engage us need to be inclusive. It’s no longer about talking to Share XThe power of communication: engaging diverse groups in healthcarehttps://pharmaphorum.com/views-and-analysis/the-power-of-communication-engaging-diverse-groups-in-healthcare/
The next generation of immunotherapy? Innate Pharma targets NK cellsClinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to Share XThe next generation of immunotherapy? Innate Pharma targets NK cellshttps://pharmaphorum.com/views-and-analysis/the-next-generation-of-immunotherapy-innate-pharma/
COVID heralds a faster future for drug development (if stakeholders can collaborate)COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right Share XCOVID heralds a faster future for drug development (if stakeholders can collaborate)https://pharmaphorum.com/views-and-analysis/covid-heralds-a-faster-future-for-drug-development-if-stakeholders-can-work-together/
Jan van de Winkel: Building Europe’s biotech powerhouse at GenmabJan van de Winkel has overseen one of biotech’s big success stories since he took over Genmab’s CEO Share XJan van de Winkel: Building Europe’s biotech powerhouse at Genmabhttps://pharmaphorum.com/views-and-analysis/jan-van-de-winkel-building-europes-biotech-powerhouse-at-genmab/
Is disability the last bastion of the representation debate?From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and Share XIs disability the last bastion of the representation debate?https://pharmaphorum.com/views-and-analysis/is-disability-the-last-bastion-of-the-representation-debate/
What Is The Best Way to Incentivise a Digital-First Sales Team?Incentivising people with KPI-linked bonuses is nothing new. Especially in commercial roles it has long been standard. The Share XWhat Is The Best Way to Incentivise a Digital-First Sales Team?https://pharmaphorum.com/views-and-analysis/what-is-the-best-way-to-incentivise-a-digital-first-sales-team/
Country focus: Hungary carves out a niche in digital pharmaAI simulated cell company Turbine is just one of many digital drug discovery firms on the rise in Share XCountry focus: Hungary carves out a niche in digital pharmahttps://pharmaphorum.com/digital/country-focus-hungary-carves-out-a-niche-in-digital-pharma/
